Investors tend to be attracted to stocks that trade at a cheap price due to the fact that they offer the possibility of great returns for not a large amount of capital invested. Small-cap companies typically trade at a lower price compared to larger companies. Investors should be aware that stocks that trade at a cheap rate, such as below $10 per share, are inherently riskier than stocks with a strong financial position and great reputation. Cheap companies have a much higher chance of wild swings in their ...

Company achieved significant commercial progress in 2023 IBSRELA® now expected to generate greater than $1.0 billion in annual U.S. net product sales revenue at peak Webcast scheduled for 7:00 PM ET / 4:00 PM PT to discuss IBS-C Market WALTHAM, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today provided an update o ...

Ardelyx, Inc. (NASDAQ:ARDX) Q3 2023 Earnings Conference Call October 31, 2023 8:00 AM ET Company Participants Caitlin Lowie - Vice President of Corporate Communications & Investor Relations Mike Raab - President & Chief Executive Officer Susan Rodriguez - Chief Commercial Officer Justin Renz - Chief Financial Officer & Chief Operations Officer Conference Call Participants Louise Chen - Cantor Yigal Nochomovitz - Citi Research Joseph Thome - TD Cowen Matt Kaplan - Ladenburg Thalmann Operator Good day and wel ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36485 ARDELYX, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 26-1303944 (State or Ot ...

Corporate Presentation Forward-Looking Statements To the extent that statements contained in this presentation are not descriptions of historical facts regarding Ardelyx, they are forward- looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor of the Private Securities Reform Act of 1995, including Ardelyx’s expectations regarding full year 2023 IBSRELA net sales revenue, potential commercial opportunities and other opportunities for the company, Ar ...

Ardelyx, Inc. (NASDAQ:ARDX) Q2 2023 Earnings Conference Call August 2, 2023 8:00 AM ET Company Participants Caitlin Lowie - Vice President, Corporate Communications and Investor Relations Mike Raab - President and Chief Executive Officer Susan Rodriguez - Chief Commercial Officer Justin Renz - Chief Financial and Operations Officer Conference Call Participants Yigal Nochomovitz - Citi Research Laura Chico - Wedbush Securities Peyton Bohnsack - TD Cowen Dennis Ding - Jeffries Matthew Kaplan - Ladenburg Thalm ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36485 ARDELYX, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 26-1303944 (State or Other J ...

Ardelyx, Inc. (NASDAQ:ARDX) Q1 2023 Results Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Caitlin Lowie - Vice President, Corporate Communications and Investor Relations Mike Raab - President and Chief Executive Officer Susan Rodriguez - Chief Commercial Officer Justin Renz - Chief Financial and Operations Officer Conference Call Participants Yigal Nochomovitz - Citi Research Laura Chico - Wedbush Securities Joseph Thome - TD Cowen Christopher Raymond - Piper Sandler & Co. Matthew Kap ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36485 ARDELYX, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 26-1303944 (State or Other ...

Ardelyx, Inc. (NASDAQ:ARDX) Q4 2022 Earnings Conference Call March 2, 2023 4:30 PM ET Company Participants Caitlin Lowie - VP, Corporate Communications and IR Mike Raab - President and CEO Justin Renz - CFO Susan Rodriguez - CCO Rob Blanks - Chief Regulatory Affairs and Quality Assurance Officer Conference Call Participants Laura Chico - Wedbush Securities Yigal Nochomovitz - Citi Peyton Bohnsack - TD Cowen Operator Good afternoon everyone and welcome to the Ardelyx Fourth Quarter 2022 Conference Call. At t ...